(2-Methyl-[1,1'-biphenyl]-3-yl)methanamine is primarily used in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure makes it a valuable building block for developing compounds with potential therapeutic effects, particularly in the areas of central nervous system (CNS) disorders and cardiovascular diseases. Additionally, it is utilized in research and development for creating novel drug candidates, especially those targeting receptor modulation or enzyme inhibition. Its application extends to organic synthesis, where it serves as a precursor for more complex molecules in medicinal chemistry.